• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南安普敦掌腱膜挛缩评分系统。

The Southampton Dupuytren's Scoring Scheme.

作者信息

Mohan Arvind, Vadher Jane, Ismail Hiba, Warwick David

机构信息

Orthopaedic Registrar, Department of Orthopaedics, Southampton University Hospitals , Southampton , UK.

出版信息

J Plast Surg Hand Surg. 2014 Feb;48(1):28-33. doi: 10.3109/2000656X.2013.794349. Epub 2013 May 13.

DOI:10.3109/2000656X.2013.794349
PMID:24428161
Abstract

The aim of this study was to construct and validate a simple patient-related outcome score to quantify the disability caused by Dupuytren's disease (DD), thus enabling prioritisation of treatment, to allow reliable audit of surgical outcome and to support future research. The Southampton Dupuytren's Scoring System (SDSS) was developed in a staged fashion according to the recommendations of The Derby Outcomes Conference. (1) Item generation; (2) Item reduction; (3) Internal consistency; (4) Test-re-test; (5) Field management; (6) Sensitivity to change standardised response mean; and (7) Criterion validity: ability of the SDSS to measure what it is supposed to measure. Internal consistency measured with Cronbach's alpha indicated acceptable reliability. The test-re-test correlation coefficient showed high reliability with SDSS. Field-testing showed SDSS ratings to be higher than the QuickDASH (Disability of the arm, shoulder and hand) ratings evaluated by the patients who answered both questionnaires. Standardised response mean was more sensitive for SDSS compared with QuickDASH showing sensitivity to change. Criterion validity was used to assess if the SDSS was measuring what it is supposed to measure comparing the SDSS with QuickDASH. A highly significant correlation was found between the two scoring systems. SDSS is a disease-specific patient-related outcome measure with a good internal consistency and performs better than QuickDASH in terms of test-re-test reliability and sensitivity to change. SDSS shows better field-testing attributes suggesting that it is a relatively more patient and practitioner friendly scoring system. This study proposes to the SDSS is a useful patient-related outcome measure for DD.

摘要

本研究的目的是构建并验证一个简单的患者相关结局评分系统,以量化由杜普伊特伦挛缩症(DD)导致的残疾程度,从而实现治疗的优先级排序,以便对手术结果进行可靠的评估,并为未来的研究提供支持。南安普敦杜普伊特伦挛缩症评分系统(SDSS)是根据德比结果会议的建议分阶段开发的。(1)条目生成;(2)条目缩减;(3)内部一致性;(4)重测;(5)现场管理;(6)对变化的敏感性——标准化反应均值;以及(7)效标效度:SDSS测量其预期测量内容的能力。用克朗巴哈α系数测量的内部一致性表明可靠性可接受。重测相关系数显示SDSS具有高可靠性。现场测试表明,SDSS评分高于同时回答两份问卷的患者所评估的QuickDASH(手臂、肩部和手部残疾)评分。与QuickDASH相比,SDSS的标准化反应均值对变化更敏感。使用效标效度通过将SDSS与QuickDASH进行比较来评估SDSS是否在测量其预期测量的内容。在两个评分系统之间发现了高度显著的相关性。SDSS是一种针对特定疾病的患者相关结局测量方法,具有良好的内部一致性,并且在重测可靠性和对变化的敏感性方面比QuickDASH表现更好。SDSS显示出更好的现场测试属性,表明它是一个相对更受患者和医生欢迎的评分系统。本研究表明SDSS是一种用于DD的有用的患者相关结局测量方法。

相似文献

1
The Southampton Dupuytren's Scoring Scheme.南安普敦掌腱膜挛缩评分系统。
J Plast Surg Hand Surg. 2014 Feb;48(1):28-33. doi: 10.3109/2000656X.2013.794349. Epub 2013 May 13.
2
A patient-reported outcome measure for patients with Dupuytren's disease.用于患有杜普伊特伦挛缩症患者的患者报告结局测量工具。
Dan Med J. 2020 Jun 1;67(6):A03190190.
3
Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability.手部疾病风湿单元(URAM)量表:一种评估特定于杜普伊特伦病的残疾的工具的开发和验证。
Arthritis Care Res (Hoboken). 2011 Oct;63(10):1448-55. doi: 10.1002/acr.20564.
4
Objective and subjective assessment of Dupuytren's contracture.对杜普伊特伦挛缩的客观和主观评估。
Acta Chir Plast. 2023 Summer;65(2):74-78. doi: 10.48095/ccachp202374.
5
Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren's disease.用于Dupuytren病时,手臂、肩部和手部患者报告结局量表(DASH)及快速DASH的效度。
J Hand Surg Eur Vol. 2016 Jul;41(6):589-99. doi: 10.1177/1753193415601350. Epub 2015 Aug 25.
6
The minimal clinically important difference of the Southampton Dupuytren's Scoring Scheme.南安普敦掌腱膜挛缩评分方案的最小临床重要差异。
J Plast Surg Hand Surg. 2023 Feb-Dec;57(1-6):539-544. doi: 10.1080/2000656X.2023.2172024. Epub 2023 Feb 2.
7
The QuickDASH score: a patient-reported outcome measure for Dupuytren's surgery.快速DASH评分:一种用于Dupuytren手术的患者报告结局指标。
J Hand Ther. 2011 Jan-Mar;24(1):15-20; quiz 21. doi: 10.1016/j.jht.2010.08.006. Epub 2010 Nov 24.
8
Measuring functional outcome in Dupuytren's disease: A systematic review of patient-reported outcome measures.测量杜普伊特伦挛缩症的功能结局:对患者报告结局指标的系统评价
J Hand Ther. 2022 Oct-Dec;35(4):613-627. doi: 10.1016/j.jht.2021.04.010. Epub 2021 Apr 14.
9
What patients want from the treatment of Dupuytren's disease--is the Unité Rhumatologique des Affections de la Main (URAM) scale relevant?患者对掌腱膜挛缩症治疗的期望——手部风湿病单元(URAM)量表是否适用?
J Hand Surg Eur Vol. 2015 Feb;40(2):150-4. doi: 10.1177/1753193414524689. Epub 2014 Feb 21.
10
Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren's contracture: validity evidence using Rasch modeling.用于评估杜普伊特伦挛缩症患者上肢、肩部和手部功能障碍的DASH量表的心理测量学评价:基于拉施模型的效度证据
BMC Musculoskelet Disord. 2014 Oct 30;15:361. doi: 10.1186/1471-2474-15-361.

引用本文的文献

1
[Surgical and Injection Interventions for Dupuytren's Disease: A Systematic Review Protocol].[掌腱膜挛缩症的手术及注射干预:一项系统评价方案]
Rev Bras Ortop (Sao Paulo). 2025 Sep 8;60(3):s00451811596. doi: 10.1055/s-0045-1811596. eCollection 2025 Jun.
2
Surgical and Injection Interventions for Dupuytren's Disease: A Systematic Review Protocol.掌腱膜挛缩症的手术和注射干预:一项系统评价方案
Rev Bras Ortop (Sao Paulo). 2025 Sep 8;60(3):s00451811595. doi: 10.1055/s-0045-1811595. eCollection 2025 Jun.
3
Randomized Controlled Trial Comparing the Clinical Effectiveness of Collagenase Injection (Xiaflex) and Palmar Fasciectomy in the Management of Dupuytren's Contracture.
比较胶原酶注射(Xiaflex)与掌腱膜切除术治疗掌腱膜挛缩症临床疗效的随机对照试验
Plast Surg (Oakv). 2024 Nov;32(4):659-666. doi: 10.1177/22925503231161066. Epub 2023 Mar 13.
4
The Italian version of the Unité Rhumatologique des Affections de la Main (URAM) for Dupuytren's disease: The URAM-I(10).意大利版手部风湿性疾病统一评估量表(URAM)用于杜普伊特伦挛缩症:URAM-I(10)
Hand Ther. 2021 Sep;26(3):91-101. doi: 10.1177/17589983211034532. Epub 2021 Jul 27.
5
Validation of a Handprint for Clinical Evaluation of Dupuytren's Contracture.用于杜普伊特伦挛缩临床评估的手印验证
J Hand Microsurg. 2021 Aug 25;15(3):181-187. doi: 10.1055/s-0041-1735347. eCollection 2023 Jun.
6
Epineural Methylene Blue Injection May Aid Localization of Digital Nerves in Dupuytren's Surgery.神经外膜亚甲蓝注射有助于在掌腱膜挛缩切开术中定位指神经。
Eur Surg Res. 2022;63(3):105-113. doi: 10.1159/000519666. Epub 2021 Oct 22.
7
Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial.手术筋膜切除术与胶原酶注射治疗复发性杜普伊特伦病的随机对照试验研究方案。
BMJ Open. 2019 Feb 25;9(2):e024424. doi: 10.1136/bmjopen-2018-024424.
8
Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.评估治疗杜普伊特伦挛缩病的最佳功能结局测量指标:系统评价及对未来实践的建议。
BMC Musculoskelet Disord. 2013 Apr 10;14:131. doi: 10.1186/1471-2474-14-131.